Literature DB >> 26388228

Inflammatory diseases: Hydrogel drug delivery for inflammatory bowel disease.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26388228     DOI： 10.1038/nrd4744

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.

Authors:  Sufeng Zhang; Joerg Ermann; Marc D Succi; Allen Zhou; Matthew J Hamilton; Bonnie Cao; Joshua R Korzenik; Jonathan N Glickman; Praveen K Vemula; Laurie H Glimcher; Giovanni Traverso; Robert Langer; Jeffrey M Karp
Journal:  Sci Transl Med       Date:  2015-08-12       Impact factor: 17.956
  1 in total
  1 in total

1.  AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.

Authors:  Justin T Easley; Christina L M Maruyama; Ching-Shuen Wang; Olga J Baker
Journal:  Physiol Rep       Date:  2016-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.